2.19
price down icon5.60%   -0.13
after-market アフターアワーズ: 2.25 0.06 +2.74%
loading
前日終値:
$2.32
開ける:
$2.39
24時間の取引高:
1.53M
Relative Volume:
0.31
時価総額:
$176.56M
収益:
$101.21M
当期純損益:
$-569.00K
株価収益率:
-109.50
EPS:
-0.02
ネットキャッシュフロー:
$-56.88M
1週間 パフォーマンス:
-8.37%
1か月 パフォーマンス:
-3.52%
6か月 パフォーマンス:
+157.65%
1年 パフォーマンス:
+58.70%
1日の値動き範囲:
Value
$2.19
$2.39
1週間の範囲:
Value
$2.18
$2.47
52週間の値動き範囲:
Value
$0.40
$3.095

Cytomx Therapeutics Inc Stock (CTMX) Company Profile

Name
名前
Cytomx Therapeutics Inc
Name
セクター
Healthcare (1161)
Name
電話
650.515.3185
Name
住所
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
職員
121
Name
Twitter
@cytomxinc
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
CTMX's Discussions on Twitter

CTMX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CTMX
Cytomx Therapeutics Inc
2.19 365.50M 101.21M -569.00K -56.88M -0.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-15 アップグレード H.C. Wainwright Neutral → Buy
2025-04-14 再開されました Piper Sandler Overweight
2024-05-28 アップグレード Piper Sandler Neutral → Overweight
2024-05-09 アップグレード Wedbush Neutral → Outperform
2024-05-06 アップグレード Jefferies Hold → Buy
2024-04-22 アップグレード JP Morgan Underweight → Neutral
2022-11-14 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-07-07 ダウングレード Jefferies Buy → Hold
2022-07-07 ダウングレード Mizuho Buy → Neutral
2022-07-07 ダウングレード Piper Sandler Overweight → Neutral
2022-07-07 ダウングレード Wedbush Outperform → Neutral
2022-06-24 開始されました BMO Capital Markets Outperform
2022-01-18 アップグレード Barclays Underweight → Overweight
2021-11-15 開始されました BTIG Research Buy
2021-05-28 ダウングレード Barclays Equal Weight → Underweight
2021-03-29 開始されました JP Morgan Overweight
2021-03-23 アップグレード Jefferies Hold → Buy
2020-09-22 ダウングレード Guggenheim Buy → Neutral
2020-06-01 ダウングレード Jefferies Buy → Hold
2020-05-14 繰り返されました H.C. Wainwright Buy
2020-03-24 アップグレード Wedbush Neutral → Outperform
2020-03-04 開始されました Barclays Equal Weight
2019-11-20 開始されました Guggenheim Buy
2019-11-11 ダウングレード Wedbush Outperform → Neutral
2019-06-13 開始されました Mizuho Buy
2019-05-14 開始されました Cantor Fitzgerald Overweight
2019-03-11 開始されました Barclays Overweight
2018-11-26 開始されました Piper Jaffray Overweight
2018-10-15 開始されました Goldman Neutral
2018-09-13 開始されました H.C. Wainwright Buy
2018-06-01 開始されました SunTrust Buy
2018-01-05 開始されました Citigroup Buy
2017-09-08 開始されました Wedbush Outperform
2017-03-27 開始されました H.C. Wainwright Buy
2017-03-02 開始されました Instinet Buy
2017-01-03 ダウングレード Oppenheimer Outperform → Perform
2015-11-02 開始されました Oppenheimer Outperform
すべてを表示

Cytomx Therapeutics Inc (CTMX) 最新ニュース

pulisher
05:09 AM

What is the risk reward ratio of investing in CytomX Therapeutics Inc. stockFinancial News Planner For Consistent Profits - jammulinksnews.com

05:09 AM
pulisher
12:11 PM

This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga

12:11 PM
pulisher
10:49 AM

How volatile is CytomX Therapeutics Inc. stock compared to the marketMarket Forecast Opportunities Backed By Experts - jammulinksnews.com

10:49 AM
pulisher
08:22 AM

CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025 | CTMX Stock News - GuruFocus

08:22 AM
pulisher
08:08 AM

CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025 - The Manila Times

08:08 AM
pulisher
08:00 AM

CytomX Therapeutics Sets Q2 Earnings Date: Biotech Leader to Update on Masked Biologics Progress - Stock Titan

08:00 AM
pulisher
06:55 AM

Oppenheimer initiates CytomX Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada

06:55 AM
pulisher
05:38 AM

How does CytomX Therapeutics Inc. compare to its industry peersEntry Signal Report For Beginners - jammulinksnews.com

05:38 AM
pulisher
03:51 AM

Does CytomX Therapeutics Inc. stock perform well during market downturnsValue Investing Recommendation For Every Investor - jammulinksnews.com

03:51 AM
pulisher
Jul 30, 2025

What makes CytomX Therapeutics Inc. stock price move sharplyEntry Signal Report For Beginners - jammulinksnews.com

Jul 30, 2025
pulisher
Jul 30, 2025

CytomX Therapeutics Inc. Reaches Critical Trendline SupportSwing Trade Entry With Volume Triggers Released - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Can CytomX Therapeutics Inc. hit a new high this monthIntraday Trend Analysis for Fast Gains Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

CytomX Therapeutics Inc. Added to Custom Quant Screener TodayEntry and Exit Strategy Optimizer Tool Tested - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

How strong is CytomX Therapeutics Inc. company’s balance sheetAI Powered Strategy For Beginners - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for CytomX Therapeutics Inc. in the next 12 monthsFree Wealth Planning Blueprint - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying CytomX Therapeutics Inc. stockGet expert analysis on top stock picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 25, 2025

What drives CytomX Therapeutics Inc. stock priceStrong return on assets - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

CytomX (CTMX) Shares Promising Early Results for CRC Drug Candidate - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about CytomX Therapeutics Inc. stockSkyrocketing returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

CytomX Therapeutics Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

10 Best Performing Penny Stocks So Far in 2025 - Insider Monkey

Jul 25, 2025
pulisher
Jul 20, 2025

Is CytomX Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - Autocar Professional

Jul 20, 2025
pulisher
Jul 16, 2025

Why CytomX Therapeutics Inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser

Jul 16, 2025

Cytomx Therapeutics Inc (CTMX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
大文字化:     |  ボリューム (24 時間):